G. Michael Flannigan

Whiteley Clinic — United Kingdom

Medicine · Health Sciences

10h-index353citations29works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging and Pathology Studies(5), Bladder and Urothelial Cancer Treatments(4), Prostate Cancer Diagnosis and Treatment(3), Urinary Bladder and Prostate Research(3), Genomics, phytochemicals, and oxidative stress(3)

Publications29 total

Surgical equipment for benign prostate surgery: the relative merits of uniploar diathermy resection, plasma kinetic resection and laser vaporisation of the prostate.
PubMed·2012· 1 cited
The role and responsibilities of behavior technicians in behavioral treatment and therapy
Journal of Veterinary Behavior·2007· 4 cited
The role and limitations of trainers in behavior treatment and therapy
Journal of Veterinary Behavior·2007· 10 cited
Analysis of NAD(P)H:quinone oxidoreductase-1 (NQO1), Cytochrome P450 Oxidoreductase (P450R) and Glucose transporter 1 (Glut-1) protein expression suggests a possible role for EO9 in the treatment of invasive bladder cancer
2006· 2 cited
Long Term Follow Up of Men with Alfuzosin who Voided Successfully Following Acute Urinary Retention*
International Urology and Nephrology·2005· 4 cited
NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin C.
International Journal of Oncology·2004· 14 cited
Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: Relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy
International Journal of Cancer·2004· 27 citedOpen Access
Macroscopic single‐layer vasectomy reversal technique
British Journal of Urology·2003· 3 cited
Randomised, Placebo Controlled, Double Blind Study of Alfuzosin SR in Patients Undergoing Trial without Catheter Following Acute Urinary Retention
European Urology·2002· 41 cited
A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9
British Journal of Cancer·2001· 52 citedOpen Access
Telomerase activity in malignant and benign bladder conditions.
International Journal of Molecular Medicine·1998· 22 cited
Imaging, stone disease
Current Opinion in Urology·1997
Role of P-Glycoprotein inChemoresistant SuperficialBladder Tumours
European Urology·1997· 3 cited
Imaging, stone disease
Current Opinion in Urology·1997
Ultrasound in urological emergency: Results of self audit and implications for training
International Urology and Nephrology·1996· 9 cited
Imaging, stone disease
Current Opinion in Urology·1996
Imaging, stone disease
Current Opinion in Urology·1995
Extracorporeal shock wave lithotripsy for lower ureteric stones through perineal region
British Journal of Urology·1995
Editorial comment
Current Opinion in Urology·1995
Growth characteristics of early passage cell lines compared with established TCC bladder lines
Urological Research·1994
page 1 of 2Next →

Frequent Co-authors

Tariq Shah(7), Rajiv Puri(5), V. Nargund(5), Roger M. Phillips(4), P. A. HAMILTON STEWART(4), Brian Naylor(3), John E. Brown(3), RANDALL CLIFFORD(3), J. M. TOWLER(3), Saurajyoti Basu(3), Jason H. Gill(3), Guzanfar A. Choudry(2), Victor Palit(2), Yasmin Elmasry(2), R.A. Carver(2), Andrew Yule(2), Nicholas Madden(2), Paul M. Loadman(2), Sandie Martin(2), Andy Scally(2)